Gene · 9211
Papers3,019
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,019
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune dysregulation and epileptogenesis. | Neurol Sci | 2026 | 42820995 | PubTator, text mining | PubMed |
| Beyond Nerve Hyperexcitability: Potential Implications of Cerebrospinal Fluid CASPR2 Antibodies for Central Pain Processing in Isaacs Syndrome: A Case-Based Systematic Review. | Pain Ther | 2026 | 42809178 | PubTator, text mining | PubMed |
| Autoimmune encephalitis and gastrointestinal inflammation: Building evidence for a gut-brain connection. | J Neuroimmunol | 2026 | 42785101 | PubTator, text mining | PubMed |
| Antibody-Dependent Cellular Phagocytosis and Cytotoxicity in Patients With LGI1 and CASPR2 Encephalitis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 42777167 | PubTator, text mining | PubMed |
| Structural Brain Changes Are Linked to Clinical and Cognitive Outcomes in Anti-LGI1 Encephalitis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 42753224 | PubTator, text mining | PubMed |
| Hippocampal texture asymmetry features on 18F-FDG PET differentiating anti-LGI1 and anti-GABABR encephalitis. | Front Immunol | 2026 | 42712541 | PubTator, text mining | PubMed |
| Autoimmune Encephalitis: A Case Series from a Tertiary Care Center in South India. | Neurol India | 2026 | 42700126 | PubTator, text mining | PubMed |
| Olfactory Hallucinations as the Initial Symptom of Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: A Case Report and Review of the Literature. | Cureus | 2026 | 42688849 | PubTator, text mining | PubMed |
| Autoimmune-associated epilepsy: definitions and diagnosis - a narrative review. | Arq Neuropsiquiatr | 2026 | 42674427 | PubTator, text mining | PubMed |
| [Anti-LGI1 antibody encephalitis: A monocentric retrospective series of seven patients]. | Rev Med Interne | 2026 | 42660711 | PubTator, text mining | PubMed |
| Micro-Engineered Smart ZnO Inverse Opal Electrodes with AgCuS Nanocrystal Amplification for Ultrasensitive Anti-LGI1 Antibody Detections. | Micromachines (Basel) | 2026 | 42653576 | PubTator, text mining | PubMed |
| Prevalence and clinical correlates of autoimmune and infection-related antibodies in unexplained seizures in western China. | BMC Immunol | 2026 | 42632885 | PubTator, text mining | PubMed |
| Facio-Brachial Dystonic Seizures as an Atypical Presentation of Anti-IgLON5 Disease. | J Cent Nerv Syst Dis | 2026 | 42621167 | PubTator, text mining | PubMed |
| Sick sinus syndrome: A harbinger of anti-LGI1 encephalitis. | Epilepsia | 2026 | 42615835 | PubTator, text mining | PubMed |
| Autoimmune encephalitis in children: Frequency, clinical spectrum and antibody profile at a tertiary care center in northern India. | Indian J Med Microbiol | 2026 | 42586483 | PubTator, text mining | PubMed |
| Different oral prednisone tapering regimens for the treatment of anti-LGI1 encephalitis: A multicenter cohort study. | Clin Neurol Neurosurg | 2026 | 42585759 | PubTator, text mining | PubMed |
| Relapse risk and functional outcomes in anti-LGI1 encephalitis: A multicenter retrospective analysis. | Ther Adv Neurol Disord | 2026 | 42572567 | PubTator, text mining | PubMed |
| Autoimmune encephalitis in older adults: Atypical presentation, therapeutic approaches and implication for diagnostic criteria. | J Neurol Sci | 2026 | 42567003 | PubTator, text mining | PubMed |
| Case Report: Mercury exposure and anti-LGI1/Caspr2 autoimmune encephalitis: a case series and literature review on the paradoxical worsening after chelation therapy. | Front Immunol | 2026 | 42564983 | PubTator, text mining | PubMed |
| Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 42546229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9211/papers